Atherogenic lipoproteins: mediators of glomerular injury.
Kamanna
V S
VS
Roh
D D
DD
Kirschenbaum
M A
MA
D000818:Animals; D001055:Apolipoproteins B / Q000378:metabolism*; D005923:Glomerulosclerosis, Focal Segmental / Q000209:etiology / Q000378:metabolism; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology* / Q000378:metabolism; D007678:Kidney Glomerulus / Q000473:pathology; D008077:Lipoproteins, LDL / Q000378:metabolism*; D008079:Lipoproteins, VLDL / Q000378:metabolism*; D008954:Models, Biological; D009402:Nephrosis, Lipoid / Q000209:etiology / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism*
D001055:Apolipoproteins B; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D014280:Triglycerides; C030106:very low density lipoprotein triglyceride